The surface rhamnopolysaccharide epa of enterococcus faecalis is a key determinant of intestinal colonization

Journal of Infectious Diseases

Volumn 211, Issue 1, 2015, Pages 62-71

  Rigottier Gois, Lionel ^a   Madec, Clément ^a,b,c,d   Navickas, Albertas ^a,b,c,d   Matos, Renata C ^a,b,c,d   Akary Lepage, Elodie ^a,b,c,d   Mistou, Michel Yves ^a   Serror, Pascale ^a  

^a UMR1319 MICALIS   (France)

^b Institut de Biologie Physico Chimique   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSTITUT JEAN PIERRE BOURGIN   (France)

Author keywords

Enterococcus faecalis; intestinal colonization; opportunistic infection; pathobiont.; rhamnopolysaccharide

Indexed keywords

CLINDAMYCIN; GLYCOSYLTRANSFERASE; LINCOSAMIDE; POLYSACCHARIDE; RHAMNOPOLYSACCHARIDE; SUGAR; UNCLASSIFIED DRUG; VANCOMYCIN; BILE ACID; MEMBRANE ANTIGEN; RHAMNOSE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; BLOODSTREAM INFECTION; COMMENSAL; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; HUMAN; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; LYMPH NODE; MALE; MICROFLORA; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BACTERIAL GENE; CELL WALL; GENETICS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

ANIMALS; ANTIGENS, SURFACE; BILE ACIDS AND SALTS; CELL WALL; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECALIS; GENES, BACTERIAL; GLYCOSYLTRANSFERASES; GRAM-POSITIVE BACTERIAL INFECTIONS; INTESTINES; MALE; MICE; MICROBIOTA; POLYSACCHARIDES; RHAMNOSE;

EID: 84922439976     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu402     Document Type: Article

References (50)

1. Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 2011; 23:473-80.
2. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-23.
3. Brandl K, Plitas G, Mihu CN, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455: 804-7.
4. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280.
5. Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004; 9:180-97.
6. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010; 201:534-43.
7. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14:685-90.
8. Liss BJ, Vehreschild JJ, Cornely OA, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012; 40:613-9.
9. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 2013; 32:841-50.
10. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996; 17:36-41.
11. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
12. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012; 10:266-78.
13. Gilmore MS, Coburn PS, Nallapareddy SR, Murray BE. Enterococcal virulence. In: Gilmore MS, Clewell DB, Courvalin P, Dunny GM, Murray BE, Rice LB, eds. The enterococci: pathogenesis, molecular biology, and antibiotic resistance. Washington, DC: ASM, 2002:301-54.
14. Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55:905-14.
15. Ubeda C, Taur Y, Jenq RR, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120:4332-41.
16. van Vliet MJ, Tissing WJ, Dun CA, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 2009; 49:262-70.
17. Solheim M, Aakra A, Vebo H, Snipen L, Nes IF. Transcriptional responses of Enterococcus faecalis V583 to bovine bile and sodium dodecyl sulfate. Appl Environ Microbiol 2007; 73:5767-74.
18. Bohle LA, Faergestad EM, Veiseth-Kent E, et al. Identification of proteins related to the stress response in Enterococcus faecalis V583 caused by bovine bile. Proteome Sci 2010; 8:37.
19. Giard JC, Laplace JM, Rince A, et al. The stress proteome of Enterococcus faecalis. Electrophoresis 2001; 22:2947-54.
20. Kristich CJ, Wells CL, Dunny GM. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc Natl Acad Sci U S A 2007; 104:3508-13.
21. Pultz NJ, Shankar N, Baghdayan AS, Donskey CJ. Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice. FEMS Microbiol Lett 2005; 242:217-9.
22. Lindenstrauss AG, Ehrmann MA, Behr J, et al. Transcriptome analysis of Enterococcus faecalis toward its adaption to surviving in the mouse intestinal tract. Arch Microbiol 2014; 196:423-33.
23. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9:454-60.
24. Ruiz-Garbajosa P, Bonten MJ, Robinson DA, et al. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 2006; 44:2220-8.
25. Kuch A, Willems RJ, Werner G, et al. Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother 2011; 67:551-8.
26. Nallapareddy SR, Wenxiang H, Weinstock GM, Murray BE. Molecular characterization of a widespread, pathogenic, and antibiotic resistancereceptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island. J Bacteriol 2005; 187:5709-18.
27. Sahm DF, Kissinger J, Gilmore MS, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33:1588-91.
28. Solheim M, Brekke MC, Snipen LG, Willems RJ, Nes IF, Brede DA. Comparative genomic analysis reveals significant enrichment of mobile genetic elements and genes encoding surface structure-proteins in hospital- associated clonal complex 2 Enterococcus faecalis. BMC Microbiol 2011; 11:3.
29. Lepage E, Brinster S, Caron C, et al. Comparative genomic hybridization analysis of Enterococcus faecalis: identification of genes absent from food strains. J Bacteriol 2006; 188:6858-68.
30. Rigottier-Gois L, Alberti A, Houel A, et al. Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors. PLoS One 2011; 6:e29023.
31. Reffuveille F, Serror P, Chevalier S, et al. The prolipoprotein diacylglyceryl transferase (Lgt) of Enterococcus faecalis contributes to virulence. Microbiology 2012; 158:816-25.
32. Lay C, Dore J, Rigottier-Gois L. Separation of bacteria of the Clostridium leptum subgroup from the human colonic microbiota by fluorescenceactivated cell sorting or group-specific PCR using 16S rRNA gene oligonucleotides. FEMS Microbiol Ecol 2007; 60:513-20.
33. Matos RC, Lapaque N, Rigottier-Gois L, et al. Enterococcus faecalis prophage dynamics and contributions to pathogenic traits. PLoS Genet 2013; 9:e1003539.
34. Maguin E, Duwat P, Hege T, Ehrlich D, Gruss A. New thermosensitive plasmid for gram-positive bacteria. J Bacteriol 1992; 174:5633-8.
35. Brinster S, Furlan S, Serror P. C-terminal WxL domain mediates cell wall binding in Enterococcus faecalis and other gram-positive bacteria. J Bacteriol 2007; 189:1244-53.
36. Dumoulin R, Cortes-Perez N, Gaubert S, et al. Enterococcal Rgg-like regulator ElrR activates expression of the elrA operon. J Bacteriol 2013; 195:3073-83.
37. Chapot-Chartier MP, Vinogradov E, Sadovskaya I, et al. Cell surface of Lactococcus lactis is covered by a protective polysaccharide pellicle. J Biol Chem 2010; 285:10464-71.
38. Caliot E, Dramsi S, Chapot-Chartier MP, et al. Role of the Group B antigen of Streptococcus agalactiae: a peptidoglycan-anchored polysaccharide involved in cell wall biogenesis. PLoS Pathog 2012; 8:e1002756.
39. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180:384-90.
40. Teng F, Singh KV, Bourgogne A, Zeng J, Murray BE. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect Immun 2009; 77:3759-67.
41. Hancock LE, Gilmore MS. The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A 2002; 99:1574-9.
42. Pazur JH. beta-D-Glucose 1-phosphate. A structural unit and an immunological determinant of a glycan from streptococcal cell walls. J Biol Chem 1982; 257:589-91.
43. Pazur JH, Anderson JS, Karakawa WW. Glycans from streptococcal cell walls. Immunological and chemical properties of a new diheteroglycan from Streptococcus faecalis. J Biol Chem 1971; 246:1793-8.
44. Bateman A, Rawlings ND. The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci 2003; 28:234-7.
45. Eldholm V, Johnsborg O, Straume D, et al. Pneumococcal CbpD is a murein hydrolase that requires a dual cell envelope binding specificity to kill target cells during fratricide. Mol Microbiol 2010; 76: 905-17.
46. Hondorp ER, McIver KS. The Mga virulence regulon: infection where the grass is greener. Mol Microbiol 2007; 66:1056-65.
47. Lairson LL, Henrissat B, Davies GJ, Withers SG. Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 2008; 77:521-55.
48. Palmer KL, Godfrey P, Griggs A, et al. Comparative genomics of enterococci: variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. MBio 2012;3:e00318-11.
49. Coyne MJ, Chatzidaki-Livanis M, Paoletti LC, Comstock LE. Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci U S A 2008; 105:13099-104.
50. Fanning S, Hall LJ, Cronin M, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012; 109:2108-13.